Prolapse repair system shows efficacy at 6 months
Using the pelvic organ prolapse quantification exam, the Elevate Anterior and Apical Prolapse Repair System (American Medical Systems, Minnetonka, MD) has demonstrated 6-month efficacy rates of stage 1 or less to be 86.3% for anterior and 98.8% for apical prolapse, according to findings from a prospective, multicenter study.
Using the pelvic organ prolapse quantification exam, the Elevate Anterior and Apical Prolapse Repair System (American Medical Systems, Minnetonka, MN) has demonstrated 6-month efficacy rates of stage 1 or less to be 86.3% for anterior and 98.8% for apical prolapse, according to findings from a prospective, multicenter study.
The study included 142 women enrolled at 16 centers in the United States and Europe. When questioned about quality of life benefits post-procedure, 94.7% of patients reported feeling some or a lot of improvement.
"The Elevate Anterior and Apical system, completed with a single vaginal incision and no external needle passes, has shown at 6 months to be effective at treating both anterior and apical prolapse," said principal investigator Edward J. Stanford, MD, of the University of Tennessee Health Science Center, Memphis. "The results of this study were especially significant given that many of the patients had severe stage 3 or 4 prolapse."
Study results were presented at the Society for Urodynamics & Female Urology winter meeting in Phoenix.
Dr. Stanford and his co-authors on the study are consultants to AMS.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.
